Aarti Pharmalabs Limited

NSE AARTIPHARM.NS

Aarti Pharmalabs Limited Debt to Equity Ratio for the year ending March 31, 2024: 0.16

Aarti Pharmalabs Limited Debt to Equity Ratio is 0.16 for the year ending March 31, 2024, a 17.96% change year over year. Debt to equity ratio represents the financing from debt versus equity. Higher ratio indicates more debt reliance, suggesting potential risk.
  • Aarti Pharmalabs Limited Debt to Equity Ratio for the year ending March 31, 2023 was 0.14, a -99.99% change year over year.
  • Aarti Pharmalabs Limited Debt to Equity Ratio for the year ending March 31, 2022 was 2,279.94.
Key data
Date Debt to Equity Ratio Debt to Income Ratio Debt to Tangible Net Worth Ratio Dividend Coverage Ratio
Market news
SV Wall Street
NSE: AARTIPHARM.NS

Aarti Pharmalabs Limited

CEO Ms. Hetal Gogri Gala
IPO Date Jan. 30, 2023
Location India
Headquarters Tower C, 401
Employees 2,095
Sector Healthcare
Industries
Pharmaceuticals Chemicals & Advanced Materials Cleaning Supplies Cosmetics Drugstores & Retail Pharmacies Fertilizers Personal Care Tobacco
Description

Aarti Pharmalabs Limited manufactures and sells active pharmaceutical ingredients, pharmaceutical intermediates, new chemical entities, and xanthine derivatives in India. The company was formerly known as Aarti Organics Limited. Aarti Pharmalabs Limited was incorporated in 2019 and is based in Mumbai, India.

StockViz Staff

February 2, 2025

Any question? Send us an email